{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:56:28Z","timestamp":1790945788528,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ygyno.2015.12.034","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T05:31:34Z","timestamp":1458711094000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Germline mutations of the DNA repair pathways in uterine serous carcinoma"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-1495","authenticated-orcid":false,"given":"Marina","family":"Frimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Levano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodriguez-Gabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Band","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2015.12.034_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.ygyno.2015.12.034_bb0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jnci\/djs345","article-title":"Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses","volume":"104","author":"Kuhn","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"23","key":"10.1016\/j.ygyno.2015.12.034_bb0015","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"Kennedy","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.034_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2011.12.415","article-title":"Hereditary ovarian cancer: beyond the usual suspects","volume":"124","author":"Pennington","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2015.12.034_bb0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2004.04.009","article-title":"Association between uterine serous carcinoma and breast cancer","volume":"94","author":"Gehrig","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/gyno.2001.6445","article-title":"Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma","volume":"83","author":"Geisler","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.034_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.01.014","article-title":"Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?","volume":"102","author":"Chan","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"7447","key":"10.1016\/j.ygyno.2015.12.034_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ygyno.2015.12.034_bb0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.034_bb0070","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2013.12.003","article-title":"Mismatch repair deficiency in ovarian cancer \u2014 molecular characteristics and clinical implications","volume":"132","author":"Xiao","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.034_bb0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/1940-6207.CAPR-11-0499","article-title":"Uterine serous carcinoma: increased familial risk for lynch-associated malignancies","volume":"5","author":"Dewdney","year":"2012","journal-title":"Cancer Prev. Res."},{"issue":"44","key":"10.1016\/j.ygyno.2015.12.034_bb0085","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.ygyno.2015.12.034_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2015.12.034_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.genom.7.080505.115630","article-title":"Predicting the effects of amino acid substitutions on protein function","volume":"7","author":"Ng","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"17","key":"10.1016\/j.ygyno.2015.12.034_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.ygyno.2015.12.034_bb0105","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks","volume":"89","author":"Henikoff","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.ygyno.2015.12.034_bb0110","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ygyno.2015.12.034_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"7319","key":"10.1016\/j.ygyno.2015.12.034_bb0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Genomes Project","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ygyno.2015.06.034","article-title":"Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma","volume":"138","author":"Jones","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2015.12.034_bb0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejso.2006.03.032","article-title":"High incidence of BRCA1\u20132 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma","volume":"32","author":"Biron-Shental","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2015.12.034_bb0135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/IGC.0b013e3181ef622d","article-title":"BRCA1\/2 germline mutations in Jewish patients with uterine serous carcinoma","volume":"20","author":"Bruchim","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"269","key":"10.1016\/j.ygyno.2015.12.034_bb0140","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.ygyno.2015.12.034_bb0145","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.24160","article-title":"Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time","volume":"115","author":"Wright","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.12.034_bb0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"Taniguchi","year":"2003","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.034_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054103","article-title":"Exploiting MEK inhibitor-mediated activation of ERalpha for therapeutic intervention in ER-positive ovarian carcinoma","volume":"8","author":"Hou","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ygyno.2015.12.034_bb0160","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2011.09.014","article-title":"p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy","volume":"48","author":"Attias-Geva","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.12.034_bb0165","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/bcr2414","article-title":"Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers","volume":"11","author":"Neuhausen","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"22","key":"10.1016\/j.ygyno.2015.12.034_bb0170","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1158\/1078-0432.CCR-10-2092","article-title":"Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wilde-type KRAS mCRC patients","volume":"16","author":"Winder","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.ygyno.2015.12.034_bb0175","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1200\/JCO.2005.06.055","article-title":"Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?","volume":"23","author":"Ollikainen","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2015.12.034_bb0180","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.034_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-005-4793-7","volume":"94","author":"Poplawski","year":"2005","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:23:38Z","timestamp":1536884618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815302377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0090825815302377"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline mutations of the DNA repair pathways in uterine serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}